Clinical Trial Update: Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors [NA]

View source ↗

Summary

Feasibility study of simvastatin in Hodgkin's lymphoma survivors appears terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease
• Hodgkin Lymphoma

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Columbia University | Conditions: Carotid Artery Disease | NA | Status: TERMINATED | Results posted: 2021-03-02